Physician profile
Anee Kaur
NPI 1417560970
$4,790.89
in general payments reported to CMS, 2019-2025
16 companies · $1,001 in 2025
The $1,001 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,764 · 2022: $33.02 · 2023: $764 · 2024: $1,229 · 2025: $1,001.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,961 · Education: $33.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,960.85 |
| Education | $33.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $1,049.89 | 2021-2025 | Aristada, Lybalvi, Vivitrol |
| Abbvie INC. | $1,019.19 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $610.40 | 2021-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Neurocrine Biosciences, INC. | $378.90 | 2021-2025 | Ingrezza |
| Lundbeck LLC | $291.49 | 2021-2025 | Rexulti |
| Teva Pharmaceuticals USA, INC. | $285.75 | 2021-2023 | Austedo Xr |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $265.52 | 2021-2025 | Caplyta |
| Tris Pharma INC | $238.72 | 2023-2024 | Dyanavel Xr, Quillivant, Quillichew Er |
| Vanda Pharmaceuticals INC. | $231.29 | 2024-2025 | Fanapt, Hetlioz |
| Sunovion Pharmaceuticals INC. | $164.36 | 2021 | |
| Janssen Pharmaceuticals, INC | $97.71 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $57.49 | 2023-2024 | Trintellix |
| Ironshore Pharmaceuticals INC. | $36.33 | 2024 | |
| Supernus Pharmaceuticals, INC. | $28.35 | 2023 | Qelbree |
| Collegium Pharmaceutical, INC. | $21.02 | 2025 | Jornay Pm |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $14.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anee Kaur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.